학술논문

Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Document Type
Article
Source
In Biology of Blood and Marrow Transplantation September 2020 26(9):1575-1580
Subject
Language
ISSN
1083-8791